Skip to main content
. Author manuscript; available in PMC: 2018 Oct 27.
Published in final edited form as: J Cardiovasc Pharmacol Ther. 2018 Mar 19;23(4):350–357. doi: 10.1177/1074248418763612

Table 3.

Infarct Size Data (Inhibitors Study).a

n IS/LV (%)

Control (DMSO) 7 54.3 ± 3.0
PFT-α 5 48.5 ± 4.8
PFT- α R 5 46.2 ± 4.5
PFT-μ 25 μmol/L/15 minutes 6 42.2 ± 5.7
PFT-μ 25 μmol/L/5 minutes 5 46.6 ± 3.7
PFT-μ 10 μmol/L/5 minutes 5 51.2 ± 4.1
PFT-μ 1 μmol/L/5 minutes 5 50.2 ± 5.5
PFT-μ 25 μmol/L R 5 42.5 ± 5.6

Abbreviations: IS, infarct size; LV, left ventricular area; PFT, pifithrin.

a

Data are mean + SEM.